Showing results 1 - 7 of 7
2025, Paper: "This project represents the first systematic assessment of the US Food and Drug Administration’s postmarket surveillance of legally marketed artificial intelligence…
May 27, 2025, Paper: "On 23 March 2025, the direct-to-consumer genetic testing company 23andMe filed a voluntary Chapter 11 petition in a US bankruptcy court.…
March 17, 2025, Paper: "In the US, health and health care artificial intelligence (AI) tools grow in a liminal regulatory space. Wedged uncomfortably between the ambits of…
March 2025, Paper: "Questions about the future of 23andMe underscore the challenges inherent to a legal system that relies on privacy policies to protect consumer data, while also…
October 10, 2024, Paper: "The European Union’s Artificial Intelligence Act (AIA), which took effect on August 1, 2024, establishes the world’s first comprehensive legal framework…
February 25, 2023, Paper: "The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA), the most substantial overhaul of Medicare since its inception, created…
December 8, 2022, Paper: "Hydroxyprogesterone caproate (Makena) is an injectable drug for the prevention of preterm birth, ie, birth prior to 37 weeks of gestation. About 1 in 10…